ALGERT GLOBAL LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 130 filers reported holding OCULAR THERAPEUTIX INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.9%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$80
-68.5%
25,480
-48.2%
0.00%
-63.6%
Q2 2023$254
-99.9%
49,230
-33.1%
0.01%
-38.9%
Q3 2022$305,000
+11.3%
73,590
+7.8%
0.02%
-14.3%
Q2 2022$274,000
+364.4%
68,280
+475.9%
0.02%
+425.0%
Q1 2022$59,000
-41.6%
11,857
+17.4%
0.00%
-69.2%
Q3 2021$101,00010,1000.01%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$32,263100.00%
Opaleye Management Inc. 6,105,900$32,178,0939.64%
DELTEC ASSET MANAGEMENT LLC 1,913,612$10,084,7352.49%
Knoll Capital Management, LLC 200,000$1,504,0002.32%
Endurant Capital Management LP 512,744$2,702,1611.39%
Knoll Capital Management, LLC 95,800$504,8660.78%
Covestor Ltd 60,008$3160.28%
Ikarian Capital, LLC 200,000$1,054,0000.24%
EAM Investors, LLC 224,211$1,181,5920.23%
Nebula Research & Development LLC 22,474$118,4380.21%
View complete list of OCULAR THERAPEUTIX INC shareholders